Virios Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Dogwood Therapeutics

10/08/2023 21:31

* Virios Therapeutics Inc  VIRI.OQ  reported a quarterly
adjusted
loss of 8 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 7 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Virios Therapeutics Inc's reported EPS for the quarter was
a
loss of 8 cents​.
    * The mean earnings estimate of analysts had risen by
about 66.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Virios Therapeutics Inc shares had risen by 13.8% this
quarter and gained 565.3% so far this year.
    * The company reported a quarterly loss of $1.44 million.
    * Wall Street's median 12-month price target for Virios
Therapeutics Inc is $3.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 08:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.07          -0.08          Missed
 Mar. 31 2023      -0.20          -0.08          Beat
 Dec. 31 2022      -0.15          -0.11          Beat
 Sep. 30 2022      -0.49          -0.28          Beat